BriaCell Therapeutics Corp. (BCTXW) Financials

BCTXW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 27.2 million 30.9 million
June 30, 2023 27.2 million 30.9 million
March 31, 2023 29.7 million 35.6 million
Dec. 31, 2022 34.2 million 35.4 million

BCTXW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -10.9 million 533816
June 30, 2023 -10.9 million 533816
March 31, 2023 -5.3 million 281189
Dec. 31, 2022 -4.0 million 266844

BCTXW Net Income

No data available :(

BCTXW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 21.3 million - -
June 30, 2023 - - -
March 31, 2023 28.2 million - -
Dec. 31, 2022 33.5 million - -

BCTXW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 16.0 million
June 30, 2023 16.0 million
March 31, 2023 15.5 million
Dec. 31, 2022 15.5 million

BCTXW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 5.2 million 2.5 million -
June 30, 2023 - 5.2 million 2.5 million -
March 31, 2023 - 3.9 million 1.8 million -
Dec. 31, 2022 - 3.1 million 1.4 million -

BCTXW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 3861
June 30, 2023 - -
March 31, 2023 - 3816
Dec. 31, 2022 - 3865

BCTXW

Price: $0

52 week price:
0.00
0.06

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 61265

Market Capitalization: 1695

Links: